TNF and osteosarcoma: Conclusions. This feasibility study in healthy dogs demonstrated thatHILP with TNFα and cisplatin was associated with a high mortality rate and does not allowus to treat dogs with spontaneous osteosarcoma with TNFα and cisplatin HILP.